Detemir insulin (Levemir) offers reduced variability for diabetes management. Emerging research highlights aggressive cardiovascular risk reduction in diabetics and potential of GLP-1 degradation inhibitors for beta cell protection.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: